Overview

Interest of Mycophenolate for CIDP Weaning

Status:
Completed

Trial end date:
2018-05-09

Target enrollment:

Participant gender:

Summary

The main objective is to study if the mycophenolate could decrease the proportion of patients who relapse during the IVIG tapering period and after the IVIG withdrawal.

Phase:

Phase 3

Details

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Treatments:

Mycophenolate mofetil
Mycophenolic Acid